| 1. Chinn LJ, Salamon KW, Desai BN.. (1981) A structure-activity relationship study of spirolactones. Contribution of the cyclopropane ring to antimineralocorticoid activity., 24 (9): [PMID:6270335] [10.1021/jm00141a020] |
| 2. Dunn WJ, Koehler MG, Grigoras S.. (1987) The role of solvent-accessible surface area in determining partition coefficients., 30 (7): [PMID:3599019] [10.1021/jm00390a002] |
| 3. Ojasoo T, Doré JC, Gilbert J, Raynaud JP.. (1988) Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis., 31 (6): [PMID:2897467] [10.1021/jm00401a015] |
| 4. Stiefl N, Baumann K.. (2003) Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique., 46 (8): [PMID:12672239] [10.1021/jm021077w] |
| 5. Andrews PR, Craik DJ, Martin JL.. (1984) Functional group contributions to drug-receptor interactions., 27 (12): [PMID:6094812] [10.1021/jm00378a021] |
| 6. Kamata S, Matsui T, Haga N, Nakamura M, Odaguchi K, Itoh T, Shimizu T, Suzuki T, Ishibashi M, Yamada F.. (1987) Aldosterone antagonists. 2. Synthesis and biological activities of 11,12-dehydropregnane derivatives., 30 (9): [PMID:3040999] [10.1021/jm00392a022] |
| 7. Silverman BD, Platt DE.. (1996) Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition., 39 (11): [PMID:8667357] [10.1021/jm950589q] |
| 8. Crivori P, Cruciani G, Carrupt PA, Testa B.. (2000) Predicting blood-brain barrier permeation from three-dimensional molecular structure., 43 (11): [PMID:10841799] [10.1021/jm990968+] |
| 9. Claire M, Faraj H, Grassy G, Aumelas A, Rondot A, Auzou G.. (1993) Synthesis of new 11 beta-substituted spirolactone derivatives. Relationship with affinity for mineralocorticoid and glucocorticoid receptors., 36 (16): [PMID:8360885] [10.1021/jm00068a018] |
| 10. Kubinyi H, Hamprecht FA, Mietzner T.. (1998) Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices., 41 (14): [PMID:9651159] [10.1021/jm970732a] |
| 11. Kotani T, Higashiura K.. (2004) Comparative molecular active site analysis (CoMASA). 1. An approach to rapid evaluation of 3D QSAR., 47 (11): [PMID:15139751] [10.1021/jm030364c] |
| 12. Pastor M, Cruciani G, McLay I, Pickett S, Clementi S.. (2000) GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors., 43 (17): [PMID:10966742] [10.1021/jm000941m] |
| 13. Farr CD, Tabet MR, Ball WJ, Fishwild DM, Wang X, Nair AC, Welsh WJ.. (2002) Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis., 45 (15): [PMID:12109909] [10.1021/jm0102811] |
| 14. Kamata S, Haga N, Mitsugi T, Kondo E, Nagata W, Nakamura M, Miyata K, Odaguchi K, Shimizu T, Kawabata T.. (1985) Aldosterone antagonists. 1. Synthesis and biological activities of 11 beta,18-epoxypregnane derivatives., 28 (4): [PMID:2984418] [10.1021/jm00382a007] |
| 15. Caron G, Ermondi G.. (2005) Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk)., 48 (9): [PMID:15857133] [10.1021/jm048980b] |
| 16. Lill MA, Winiger F, Vedani A, Ernst B.. (2005) Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals., 48 (18): [PMID:16134935] [10.1021/jm050403f] |
| 17. Schuster D, Maurer EM, Laggner C, Nashev LG, Wilckens T, Langer T, Odermatt A.. (2006) The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening., 49 (12): [PMID:16759088] [10.1021/jm0600794] |
| 18. Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, Slegers G, Vander Heyden Y, Lambert J, Beetens J, De Spiegeleer B.. (2007) Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds., 15 (22): [PMID:17827020] [10.1016/j.bmc.2007.07.050] |
| 19. Cherkasov A, Ban F, Santos-Filho O, Thorsteinson N, Fallahi M, Hammond GL.. (2008) An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin., 51 (7): [PMID:18330978] [10.1021/jm7011485] |
| 20. Marco-Contelles J, León R, de los Ríos C, Samadi A, Bartolini M, Andrisano V, Huertas O, Barril X, Luque FJ, Rodríguez-Franco MI, López B, López MG, García AG, Carreiras Mdo C, Villarroya M.. (2009) Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease., 52 (9): [PMID:19374444] [10.1021/jm801292b] |
| 21. Roll DM, Barbieri LR, Bigelis R, McDonald LA, Arias DA, Chang LP, Singh MP, Luckman SW, Berrodin TJ, Yudt MR.. (2009) The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144., 72 (11): [PMID:19863083] [10.1021/np9004882] |
| 22. Bellavance E, Luu-The V, Poirier D.. (2009) Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone., 52 (23): [PMID:19772289] [10.1021/jm900921c] |
| 23. Eignerová B, Sedlák D, Dracínský M, Bartunek P, Kotora M.. (2010) Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α., 53 (19): [PMID:20812681] [10.1021/jm100563h] |
| 24. PubChem BioAssay data set, |
| 25. Nagata N, Miyakawa M, Amano S, Furuya K, Yamamoto N, Inoguchi K.. (2011) Design and synthesis of tricyclic tetrahydroquinolines as a new series of nonsteroidal selective androgen receptor modulators (SARMs)., 21 (6): [PMID:21349712] [10.1016/j.bmcl.2011.01.073] |
| 26. PubChem BioAssay data set, |
| 27. Tukey RH, Strassburg CP.. (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease., 40 (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581] |
| 28. Nagata N, Miyakawa M, Amano S, Furuya K, Yamamoto N, Nejishima H, Inoguchi K.. (2011) Tetrahydroquinolines as a novel series of nonsteroidal selective androgen receptor modulators: structural requirements for better physicochemical and biological properties., 21 (21): [PMID:21944856] [10.1016/j.bmcl.2011.08.118] |
| 29. Ohashi R, Tamai I, Yabuuchi H, Nezu JI, Oku A, Sai Y, Shimane M, Tsuji A.. (1999) Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance., 291 (1): [PMID:10525100] |
| 30. Romiti N, Tramonti G, Chieli E.. (2002) Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line., 183 (1): [PMID:12387747] [10.1006/taap.2002.9461] |
| 31. Bossuyt X, Müller M, Hagenbuch B, Meier PJ.. (1996) Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver., 276 (1): [PMID:8786566] |
| 32. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R.. (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone., 267 (1): [PMID:1360010] [10.1016/s0021-9258(18)35757-0] |
| 33. Uhr M, Holsboer F, Müller MB.. (2002) Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins., 14 (1): [PMID:12213137] [10.1046/j.1365-2826.2002.00836.x] |
| 34. Kanai N, Lu R, Bao Y, Wolkoff AW, Schuster VL.. (1996) Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substrates., 270 (1): [PMID:8779893] [10.1152/ajprenal.1996.270.2.f319] |
| 35. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 36. Unpublished dataset, |
| 37. Gege C, Schlüter T, Hoffmann T.. (2014) Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt., 24 (22): [PMID:25305688] [10.1016/j.bmcl.2014.09.053] |
| 38. WHO Anatomical Therapeutic Chemical Classification, |
| 39. DrugMatrix, [10.6019/CHEMBL3885881] |
| 40. Martín-Martínez M, Pérez-Gordillo FL, Álvarez de la Rosa D, Rodríguez Y, Gerona-Navarro G, González-Muñiz R, Zhou MM.. (2017) Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects., 60 (7): [PMID:28051871] [10.1021/acs.jmedchem.6b01065] |
| 41. Sampathi Perera KLI, Hanson AM, Lindeman S, Imhoff A, Lu X, Sem DS, Donaldson WA.. (2018) Synthesis and evaluation of 4-cycloheptylphenols as selective Estrogen receptor-β agonists (SERBAs)., 157 [PMID:30144697] [10.1016/j.ejmech.2018.08.006] |
| 42. Reis J, Cagide F, Valencia ME, Teixeira J, Bagetta D, Pérez C, Uriarte E, Oliveira PJ, Ortuso F, Alcaro S, Rodríguez-Franco MI, Borges F.. (2018) Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors., 158 [PMID:30245401] [10.1016/j.ejmech.2018.07.056] |
| 43. Unpublished dataset, |
| 44. Passeri D, Carotti A, Pittol JMR, Ciaccioli G, Pellicciari R, van Mil SWC, Gioiello A.. (2019) Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool., 10 (8): [PMID:31673308] [10.1039/C9MD00264B] |
| 45. (2021) EUbOPEN Chemogenomics Library wave 1, [10.6019/CHEMBL4689842] |
| 46. EUbOPEN. (2022) EUbOPEN Chemogenomics Library wave 2 - DSF, [10.6019/CHEMBL5060014] |
| 47. Shim S, Krishnaiah M, Sankham MR, Kim I, Lee Y, Shin I, Oh AR, Lee HJ, Vu TNL, Park J, Choi S, Park S, Kwon Y, Fang S, Kim DK.. (2022) Discovery of (E)-3-(3-((2-Cyano-4'-dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis., 65 (14.0): [PMID:35797110] [10.1021/acs.jmedchem.2c00641] |
| 48. Li D, Bao X, Pang J, Hu X, Wang L, Wang J, Yang Z, Xu L, Wang S, Weng Q, Cui S, Hou T.. (2022) Discovery and Optimization of N-Acyl-6-sulfonamide-tetrahydroquinoline Derivatives as Novel Non-Steroidal Selective Glucocorticoid Receptor Modulators., 65 (23.0): [PMID:36399795] [10.1021/acs.jmedchem.2c01082] |
